Muñoz Bellido J L, Muñoz Criado S, García García I, Alonso Manzanares M A, Gutiérrez Zufiaurre M N, García-Rodríguez J A
Department of Microbiology, University Hospital, University of Salamanca, Spain.
Antimicrob Agents Chemother. 1997 Dec;41(12):2612-5. doi: 10.1128/AAC.41.12.2612.
The activities of ampicillin, ampicillin-sulbactam, amoxicillin, amoxicillin-clavulanic acid, ticarcillin, ticarcillin-clavulanic acid, piperacillin, piperacillin-tazobactam, aztreonam, and aztreonam-clavulanic against Stenotrophomonas maltophilia strains for which the MICs of penicillins and commercially available beta-lactam-beta-lactamase inhibitor combinations were higher than the breakpoints usually recommended for Pseudomonas aeruginosa in commercially available broth microdilution methods were tested by the agar diffusion, agar dilution, and broth microdilution methods. Time-kill curve studies were performed when discrepancies between these methods were observed. The MICs obtained by the commercially available broth microdilution method, the agar dilution method, and the broth microdilution method were almost identical. Twenty-five percent of the strains tested showed inhibition diameters of > or =15 mm for ticarcillin-clavulanic acid, and 43.7% of the strains tested showed inhibition diameters of > or =18 mm for piperacillin-tazobactam by the agar diffusion method. The time-kill curves for these strains confirmed the results obtained by dilution methods. Aztreonam-clavulanic acid (2:1) at concentrations of < or =16 microg/ml inhibited all of these strains (MIC range, 1 to 16 microg/ml). The time-kill curves confirmed this activity. The addition of piperacillin to this combination did not modify the MICs. The combination aztreonam-clavulanic acid-ticarcillin was two- to fourfold more active than aztreonam-clavulanic acid alone. We studied the inhibitory and bactericidal activities of the two most active combinations (aztreonam-clavulanic acid and aztreonam-clavulanic acid-ticarcillin) against the standard inoculum and 10 and 50 times the standard inoculum. Inoculum modifications did not modify the MICs. Both combinations showed good bactericidal activity against the standard inoculum. With 10 times the standard inoculum, minimum bactericidal concentration (MBC) results were heterogeneous (for 55% of the strains, MBCs were between the MIC and 4-fold the MIC, and for 45% of the strains MBCs were between 8- and >32-fold the MIC). With 50 times the standard inoculum, MBCs were at least 32-fold the MICs for all the strains tested.
采用琼脂扩散法、琼脂稀释法和肉汤微量稀释法,对嗜麦芽窄食单胞菌菌株进行了氨苄西林、氨苄西林 - 舒巴坦、阿莫西林、阿莫西林 - 克拉维酸、替卡西林、替卡西林 - 克拉维酸、哌拉西林、哌拉西林 - 他唑巴坦、氨曲南及氨曲南 - 克拉维酸的活性测试。这些嗜麦芽窄食单胞菌菌株对青霉素及市售β - 内酰胺 - β - 内酰胺酶抑制剂组合的最低抑菌浓度(MIC)高于市售肉汤微量稀释法中通常推荐的铜绿假单胞菌的断点值。当观察到这些方法之间存在差异时,进行了时间 - 杀菌曲线研究。通过市售肉汤微量稀释法、琼脂稀释法和肉汤微量稀释法获得的MIC几乎相同。通过琼脂扩散法,25%的受试菌株对替卡西林 - 克拉维酸的抑菌圈直径≥15 mm,43.7%的受试菌株对哌拉西林 - 他唑巴坦的抑菌圈直径≥18 mm。这些菌株的时间 - 杀菌曲线证实了稀释法获得的结果。浓度≤16 μg/ml的氨曲南 - 克拉维酸(2:1)抑制了所有这些菌株(MIC范围为1至16 μg/ml)。时间 - 杀菌曲线证实了这种活性。向该组合中添加哌拉西林并未改变MIC。氨曲南 - 克拉维酸 - 替卡西林组合的活性比单独的氨曲南 - 克拉维酸高2至4倍。我们研究了两种活性最强的组合(氨曲南 - 克拉维酸和氨曲南 - 克拉维酸 - 替卡西林)对标准接种物以及标准接种物10倍和50倍量的抑菌和杀菌活性。接种物量的改变并未改变MIC。两种组合对标准接种物均显示出良好的杀菌活性。对于标准接种物10倍量,最低杀菌浓度(MBC)结果不一致(55%的菌株,MBC在MIC至MIC的4倍之间,45%的菌株MBC在MIC的8倍至>32倍之间)。对于标准接种物50倍量,所有受试菌株的MBC至少为MIC的32倍。